129 related articles for article (PubMed ID: 14567514)
1. Effect of oral enrofloxacin and florfenicol on pigs experimentally infected with Actinobacillus pleuropneumoniae serotype 1.
Herradora LM; Martínez-Gamba R
J Vet Med A Physiol Pathol Clin Med; 2003 Jun; 50(5):259-63. PubMed ID: 14567514
[TBL] [Abstract][Full Text] [Related]
2. Experimental infections with Actinobacillus pleuropneumoniae in pigs--II. Comparison of antibiotics for oral strategic treatment.
Wallgren P; Segall T; Pedersen Mörner A; Gunnarsson A
Zentralbl Veterinarmed B; 1999 May; 46(4):261-9. PubMed ID: 10379236
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of florfenicol on experimental Actinobacillus pleuropneumonia in pigs.
Ueda Y; Ohtsuki S; Narukawa N
J Vet Med Sci; 1995 Apr; 57(2):261-5. PubMed ID: 7492643
[TBL] [Abstract][Full Text] [Related]
4. Effect of giving enrofloxacin in the diet to pigs experimentally infected with Actinobacillus pleuropneumoniae.
Smith IM; Mackie A; Lida J
Vet Rec; 1991 Jul; 129(2):25-9. PubMed ID: 1926685
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of florphenicol premix in weanling pigs experimentally infected with Actinobacillus pleuropneumoniae.
Palacios-Arriaga JM; Gutierrez-Pabello JA; Chavez-Gris G; Hernandez-Castro R
Rev Latinoam Microbiol; 2000; 42(1):27-33. PubMed ID: 10948826
[TBL] [Abstract][Full Text] [Related]
6. Experimental infections with Actinobacillus pleuropneumoniae in pigs--I. Comparison of five different parenteral antibiotic treatments.
Wallgren P; Segall T; Pedersen Mörner A; Gunnarsson A
Zentralbl Veterinarmed B; 1999 May; 46(4):249-60. PubMed ID: 10379235
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of tilmicosin in the control of experimentally induced Actinobacillus pleuropneumoniae infection in swine.
Paradis MA; Vessie GH; Merrill JK; Dick CP; Moore C; Charbonneau G; Gottschalk M; MacInnes JI; Higgins R; Mittal KR; Girard C; Aramini JJ; Wilson JB
Can J Vet Res; 2004 Jan; 68(1):7-11. PubMed ID: 14979429
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pharmacokinetics of tilmicosin in healthy pigs and pigs experimentally infected with
Xiong J; Zhu Q; Yang S; Zhao Y; Cui L; Zhuang F; Qiu Y; Cao J
N Z Vet J; 2019 Sep; 67(5):257-263. PubMed ID: 31208293
[No Abstract] [Full Text] [Related]
9. Responses of pigs to a re-challenge with Actinobacillus pleuropneumoniae after being treated with different antimicrobials following their initial exposure.
Sjölund M; de la Fuente AJ; Fossum C; Wallgren P
Vet Rec; 2009 May; 164(18):550-5. PubMed ID: 19411684
[TBL] [Abstract][Full Text] [Related]
10. Effects of different antimicrobial treatments on serum acute phase responses and leucocyte counts in pigs after a primary and a secondary challenge infection with Actinobacillus pleuropneumoniae.
Sjölund M; Fossum C; Martín de la Fuente AJ; Alava M; Juul-Madsen HR; Lampreave F; Wallgren P
Vet Rec; 2011 Jul; 169(3):70. PubMed ID: 21737462
[TBL] [Abstract][Full Text] [Related]
11. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 10 of pigs vaccinated with bacterins consisting of A. pleuropneumoniae serotype 10 grown under NAD-rich and NAD-restricted conditions.
van Overbeke I; Chiers K; Donne E; Ducatelle R; Haesebrouck F
J Vet Med B Infect Dis Vet Public Health; 2003 Aug; 50(6):289-93. PubMed ID: 14629000
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial activity of florfenicol against Actinobacillus pleuropneumoniae.
Ueda Y; Suenaga I
J Vet Med Sci; 1995 Apr; 57(2):363-4. PubMed ID: 7492665
[TBL] [Abstract][Full Text] [Related]
13. Effects of oral administration of tilmicosin on pulmonary inflammation in piglets experimentally infected with Actinobacillus pleuropneumoniae.
Nerland EM; LeBlanc JM; Fedwick JP; Morck DW; Merrill JK; Dick P; Paradis MA; Buret AG
Am J Vet Res; 2005 Jan; 66(1):100-7. PubMed ID: 15691043
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of florfenicol in healthy pigs and in pigs experimentally infected with Actinobacillus pleuropneumoniae.
Liu J; Fung KF; Chen Z; Zeng Z; Zhang J
Antimicrob Agents Chemother; 2003 Feb; 47(2):820-3. PubMed ID: 12543702
[TBL] [Abstract][Full Text] [Related]
15. Comparison of virulence of different Actinobacillus pleuropneumoniae serotypes and biotypes using an aerosol infection model.
Jacobsen MJ; Nielsen JP; Nielsen R
Vet Microbiol; 1996 Apr; 49(3-4):159-68. PubMed ID: 8734634
[TBL] [Abstract][Full Text] [Related]
16.
Papatsiros V; Tzika E; Athanasiou L; Tassis P; Chaintoutis S; Christodoulopoulos G
Microb Drug Resist; 2019 May; 25(4):603-610. PubMed ID: 30562148
[TBL] [Abstract][Full Text] [Related]
17. Recent trends in antimicrobial susceptibility and the presence of the tetracycline resistance gene in Actinobacillus pleuropneumoniae isolates in Japan.
Morioka A; Asai T; Nitta H; Yamamoto K; Ogikubo Y; Takahashi T; Suzuki S
J Vet Med Sci; 2008 Nov; 70(11):1261-4. PubMed ID: 19057148
[TBL] [Abstract][Full Text] [Related]
18. Exposure time-dependent bactericidal activities of amoxicillin against Actinobacillus pleuropneumoniae; an in vitro and In vivo pharmacodynamic model.
Tanigawa M; Sawada T
J Vet Med B Infect Dis Vet Public Health; 2003 Nov; 50(9):436-42. PubMed ID: 14633197
[TBL] [Abstract][Full Text] [Related]
19. Tissue pharmacokinetics of florfenicol in pigs experimentally infected with Actinobacillus pleuropneumoniae.
Li JZ; Fung KF; Chen ZL; Zeng ZL; Zhang J
Eur J Drug Metab Pharmacokinet; 2002; 27(4):265-71. PubMed ID: 12587956
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Korea using new standardized procedures.
Kim B; Min K; Choi C; Cho WS; Cheon DS; Kwon D; Kim J; Chae C
J Vet Med Sci; 2001 Mar; 63(3):341-2. PubMed ID: 11307940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
